Cite

HARVARD Citation

    Daver, N. et al. (n.d.). A phase II open‐label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome. European journal of cancer care. pp. 605-611. [Online]. 
  
Back to record